Health Care & Life Sciences » Biotechnology | Kitov Pharmaceuticals Holdings Ltd.

Kitov Pharmaceuticals Holdings Ltd. ADR | Key People and Executives

John Paul Waymack
Chairman & Chief Medical Officer
Isaac Israel
Chief Executive Officer & Director
Simcha Rock
Chief Financial Officer & Director
Steven Steinberg
Independent Director
Revital Stern-Raff
Independent Director
Ran Tzror
Independent Director
Arye Weber
Independent Director
Ido Agmon
Independent Director
John Paul Waymack
Chairman & Chief Medical Officer
Isaac Israel
Chief Executive Officer & Director
Simcha Rock
Chief Financial Officer & Director
Gil Ben-Menachem
Vice President-Business Development
William Berlin
Manager-Chemistry, Manufacturing & Control
Steven Steinberg
Independent Director
Pinhas Bar-Shmuel
Internal Auditor
Avraham Ben-Tzvi
Secretary & Group Chief Legal Officer
Revital Stern-Raff
Independent Director
Ran Tzror
Independent Director
Arye Weber
Independent Director
Ido Agmon
Independent Director

About Kitov Pharmaceuticals Holdings

View Profile
Address
One Azrieli Center
Tel Aviv TA 670110
Israel
Employees -
Website http://www.kitovpharma.com
Updated 07/08/2019
Kitov Pharma Ltd. is a development stage biopharmaceutical company, which engages in drug development. The firm offers Consensi and NT219. Consensi is intended to treat osteoarthritis pain and hyper tension simultaneously, while NT219 is a cancer therapy drug that delivers anti-tumor effects and increasing survical in various cancer models.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.